Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma.

Hidemi NishiKunihito GotohYoshito TomimaruShogo KobayashiKazuki SasakiYoshifumi IwagamiDaisaku YamadaHirofumi AkitaTadafumi AsaokaTakehiro NodaHidenori TakahashiMasahiro TanemuraYuichiro DokiHidetoshi Eguchi

Published in: Cancer chemotherapy and pharmacology (2023)

Our findings suggest that avadomide could be a novel therapeutic option to overcome gemcitabine resistance in patients with PDAC.

Keyphrases

locally advanced
squamous cell carcinoma
rectal cancer
radiation therapy